GlassScriptPhysician profile
Justin Thomas Mcgonigal
NPI 1972262368
$1,994.15
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,034 · 2023: $804 · 2024: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $951 · Education: $8.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $951.29 |
| Education | $8.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $764.78 | 2022-2023 | |
| Novo Nordisk INC | $290.65 | 2022-2023 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $281.14 | 2022-2024 | Airsupra, Breztri, Farxiga |
| Lilly USA, LLC | $152.95 | 2022-2023 | Mounjaro, Trulicity, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $116.11 | 2022-2023 | |
| Otsuka America Pharmaceutical, INC. | $84.23 | 2022-2023 | Abilify Asimtufii, Rexulti |
| Indivior INC. | $63.22 | 2022-2024 | Sublocade |
| Amgen INC. | $59.24 | 2022 | |
| Glaxosmithkline, LLC. | $49.32 | 2023 | Shingrix, Trelegy Ellipta |
| Exact Sciences Corporation | $28.80 | 2023 | Cologuard Collection Kit |
| Xeris Pharmaceuticals, INC. | $22.41 | 2023 | Gvoke Hypopen |
| Gilead Sciences, INC. | $18.78 | 2023 | |
| Novartis Pharmaceuticals Corporation | $18.16 | 2023 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $16.81 | 2023 | |
| Janssen Pharmaceuticals, INC | $13.97 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $13.58 | 2023 | Verquvo, Belsomra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Mcgonigal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.